Equity Field Notes from temporal sources

[DanWebzster]

PAVM is a medical device company with 4 products:

Carpex reduces the invasiveness of carpal tunnel surgery. The device may be in the final stage of FDA 510K approval process.
FDA is reviewing PAVMs cadaver study and approval could come in 6-7/18. TAM = 600,000 procedures x $1500 in the U.S.

Port IO is a vascular access device that is designed for extended inter-osseus access. PAVM is presently conducting a 7-day animal study. If this study is successful, it will go on to a human study

Disappear is an ear infection control technology

Esophageal Cancer detection device was in-licensed in April.

It seems like everything hinges on near-term FDA approval of Carpex.